Protara Therapeutics, Inc. Common Stock TARA
$3.85
+0.92%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 2026-08-11 | View → |
| 8-K | CURRENT REPORT | 2026-08-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 8-K | CURRENT REPORT | 2026-06-29 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 8-K | CURRENT REPORT | 2026-06-15 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2026-05-28 | View → |
| S-3 | REGISTRATION STATEMENT | 2026-05-14 | View → |
| 10-Q | QUARTERLY REPORT | 2026-05-13 | View → |
| 8-K | CURRENT REPORT | 2026-05-13 | View → |
| DEF 14A | PROXY STATEMENT | 2026-04-28 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-09 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-02 | View → |
| 8-K | CURRENT REPORT | 2026-03-30 | View → |
| 10-K | ANNUAL REPORT | 2026-03-10 | View → |
| 8-K | CURRENT REPORT | 2026-03-10 | View → |
| 8-K | CURRENT REPORT | 2026-02-24 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-27 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-27 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-27 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-27 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-21 | View → |
| 8-K | CURRENT REPORT | 2025-12-15 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.85
- Market Cap
- $225.74 million
- 52-Week Range
- $2.97 – $7.82
- Average Volume
- 379K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.